CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis [Phase 3]

Phase 3 trial investigating low-dose naltrexone in combination with standard treatment for endometriosis was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Milton S. Hershey Medical Center | Conditions: Endometriosis | Phase 3 | Status: TERMINATED | Results posted: 2022-11-03